MX2018013630A - Composicion veterinaria de imidacloprid, moxidectina y praziquantel de administracion topica cutanea (spot on) para tratamiento y prevencion de las ecto y endoparasitosis que afectan a los perros. - Google Patents
Composicion veterinaria de imidacloprid, moxidectina y praziquantel de administracion topica cutanea (spot on) para tratamiento y prevencion de las ecto y endoparasitosis que afectan a los perros.Info
- Publication number
- MX2018013630A MX2018013630A MX2018013630A MX2018013630A MX2018013630A MX 2018013630 A MX2018013630 A MX 2018013630A MX 2018013630 A MX2018013630 A MX 2018013630A MX 2018013630 A MX2018013630 A MX 2018013630A MX 2018013630 A MX2018013630 A MX 2018013630A
- Authority
- MX
- Mexico
- Prior art keywords
- spot
- prevention
- endoparasitoses
- praziquantel
- moxidectin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
U n a c o mp o s i c i ó n v e t e r i n a r i a mo n o d o s i s d e a p l i c a c i ó n t ó p i c a ( s p o t - o n ) p a r a c a n e s q u e c o mp r e n d e : ( a ) I mi d a c l o p r i d , e n t r e 8 , 1 8 y 1 0 , 0 0 %; ( b ) Mo x i d e c t i n a , e n t r e 2 , 8 6 y 3 , 5 0 %; 5 ( c ) P r a z i q u a n t e l , e n t r e 8 , 1 8 y 1 0 , 0 0 %; y ( d ) u n s o l v e n t e a p r ó t i c o s e l e c c i o n a d o d e D ime t i l s u l f ó x i d o ( DMS O ) , N , N - d ime t i l a c e t a mi d a ( DMA C ) , N , N - d ime t i l f o rma mi d a ( DMF ) , y s u s me z c l a s , e n t r e 6 5 , 4 5 y 8 0 , 0 0 %; j u n t o c o n e x c i p i e n t e s v e t e r i n a r i a me n t e a c e p t a b l e s , y e n d o n d e l o s 10 p o r c e n t a j e s e s t á n r e f e r i d o s a l p e s o t o t a l d e l a c o mp o s i c i ó n . U s o d e u n a c a n t i d a d e f e c t i v a d e : ( a ) I mi d a c l o p r i d , ( b ) Mo x i d e c t i n a ; ( c ) P r a z i q u a n t e l ; y ( d ) u n s o l v e n t e a p r ó t i c o s e l e c c i o n a d o d e D ime t i l s u l f ó x i d o ( DMS O ) , N , N - d ime t i l a c e t a mi d a ( DMA C ) , N , N - d ime t i l f o rma mi d a ( DMF ) y s u s me z c l a s , j u n t o c o n e x c i p i e n t e s 15 v e t e r i n a r i a me n t e a c e p t a b l e s , p a r a l a p r e p a r a c i ó n d e u n a c o mp o s i c i ó n v e t e r i n a r i a mo n o d o s i s p a r a e l t r a t a mi e n t o , c o n t r o l y p r e v e n c i ó n d e l a s e c t o y e n d o p a r a s i t o s i s d e c a n e s , e n d o n d e d i c h a c o mp o s i c i ó n v e t e r i n a r i a e s t á a d a p t a d a p a r a s e r a d mi n i s t r a d a t ó p i c a me n t e ( s p o t - o n ) .
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP160101448A AR104691A1 (es) | 2016-05-18 | 2016-05-18 | Composición veterinaria de imidacloprid, moxidectina y praziquantel de administración tópica cutánea (spot on) para tratamiento y prevención de las ecto y endoparasitosis que afectan a los perros |
| PCT/US2017/032851 WO2017201010A1 (en) | 2016-05-18 | 2017-05-16 | Veterinary composition comprising imidacloprid, moxidectin and praziquantel for cutaneous topical application (spot on), for the treatment and prevention of ecto and endoparasitoses affecting dogs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018013630A true MX2018013630A (es) | 2019-06-17 |
| MX386934B MX386934B (es) | 2025-03-18 |
Family
ID=59714807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018013630A MX386934B (es) | 2016-05-18 | 2017-05-16 | Composición veterinaria de imidacloprid, moxidectina y praziquantel de administración tópica cutánea (spot on) para tratamiento y prevención de las ecto y endoparasitosis que afectan a los perros. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10695331B2 (es) |
| EP (1) | EP3458051B1 (es) |
| JP (2) | JP2019516793A (es) |
| CN (3) | CN108883092A (es) |
| AR (1) | AR104691A1 (es) |
| ES (1) | ES2954856T3 (es) |
| MX (1) | MX386934B (es) |
| WO (1) | WO2017201010A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4013388A1 (en) * | 2019-08-14 | 2022-06-22 | Vetoquinol SA | Compositions comprising tigolaner for controlling parasites |
| CN110772509A (zh) * | 2019-10-17 | 2020-02-11 | 广东省农业科学院动物卫生研究所 | 一种吡虫啉与莫昔克丁二元醇质体及其制备方法和应用 |
| SI3815677T1 (sl) | 2019-10-30 | 2023-12-29 | Krka, D.D., Novo Mesto | Stabilni veterinarski sestavek, ki obsega moksidektin in imidakloprid |
| CN114259464B (zh) * | 2021-11-25 | 2022-11-22 | 吉林大学 | 一种复方莫昔克丁外用滴剂 |
| PE20242118A1 (es) * | 2023-12-22 | 2024-10-28 | Agrovet Market S A | Composicion farmaceutica topica que comprende una asociacion de una isoxazolina con una lactona macrociclica y un derivado de pirazino-isoquinolina para el tratamiento de infestaciones parasitarias en animales menores |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447414A (en) * | 1982-12-21 | 1984-05-08 | Cutter Laboratories, Inc. | Carnivore anthelmintics |
| JPS6058914A (ja) * | 1983-09-12 | 1985-04-05 | Shionogi & Co Ltd | イミダゾ−ル系抗真菌性外用ゲル製剤 |
| LT1610613T (lt) * | 2003-04-04 | 2017-03-27 | Merial, Inc. | Vietinio taikymo antihelmintinės veterinarinės kompozicijos |
| CA2692977A1 (en) * | 2007-07-12 | 2009-01-15 | Tragara Pharmaceuticals, Inc. | Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders |
| EP2170308A1 (en) * | 2007-07-31 | 2010-04-07 | Wyeth a Corporation of the State of Delaware | Endoparasiticidal topical compositions |
| GB0905365D0 (en) * | 2009-03-27 | 2009-05-13 | Norbrook Lab Ltd | A topical parasiticide composition |
| CN101933929A (zh) * | 2009-07-02 | 2011-01-05 | 天津瑞普生物技术股份有限公司 | 一种驱除犬、猫体内外寄生虫的复方制剂及其制备方法 |
| CA2784141C (en) | 2009-12-17 | 2017-10-24 | Merial Limited | Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles |
| JO3626B1 (ar) | 2012-02-23 | 2020-08-27 | Merial Inc | تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها |
| BR112015006055A2 (pt) * | 2012-09-19 | 2017-07-04 | Microvascular Tissues Inc | composições e métodos para o tratamento e prevenção de lesão tecidual e doença |
| CA2966517C (en) * | 2014-07-25 | 2021-03-16 | Laurent Pharmaceuticals | Solid oral formulation of fenretinide |
-
2016
- 2016-05-18 AR ARP160101448A patent/AR104691A1/es active IP Right Grant
-
2017
- 2017-05-16 EP EP17799990.1A patent/EP3458051B1/en active Active
- 2017-05-16 ES ES17799990T patent/ES2954856T3/es active Active
- 2017-05-16 US US16/074,696 patent/US10695331B2/en active Active
- 2017-05-16 CN CN201780018784.2A patent/CN108883092A/zh active Pending
- 2017-05-16 JP JP2019512939A patent/JP2019516793A/ja active Pending
- 2017-05-16 WO PCT/US2017/032851 patent/WO2017201010A1/en not_active Ceased
- 2017-05-16 CN CN202211444401.7A patent/CN115737649A/zh active Pending
- 2017-05-16 CN CN202211444380.9A patent/CN115645412A/zh active Pending
- 2017-05-16 MX MX2018013630A patent/MX386934B/es unknown
-
2021
- 2021-12-21 JP JP2021206614A patent/JP7255043B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX386934B (es) | 2025-03-18 |
| EP3458051A4 (en) | 2020-01-08 |
| US10695331B2 (en) | 2020-06-30 |
| CN108883092A (zh) | 2018-11-23 |
| US20190070158A1 (en) | 2019-03-07 |
| EP3458051A1 (en) | 2019-03-27 |
| EP3458051C0 (en) | 2023-06-07 |
| CN115645412A (zh) | 2023-01-31 |
| AR104691A1 (es) | 2017-08-09 |
| CN115737649A (zh) | 2023-03-07 |
| EP3458051B1 (en) | 2023-06-07 |
| JP2019516793A (ja) | 2019-06-20 |
| BR112018073613A2 (pt) | 2019-02-26 |
| ES2954856T3 (es) | 2023-11-27 |
| JP2022052770A (ja) | 2022-04-04 |
| JP7255043B2 (ja) | 2023-04-11 |
| WO2017201010A1 (en) | 2017-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018013630A (es) | Composicion veterinaria de imidacloprid, moxidectina y praziquantel de administracion topica cutanea (spot on) para tratamiento y prevencion de las ecto y endoparasitosis que afectan a los perros. | |
| LT3997103T (lt) | Junginiai, apimantys fibroblastų aktyvinimo baltymo ligandą, ir jų panaudojimas | |
| MX2020006128A (es) | Inhibidores de la proteina de activacion de fibroblastos. | |
| PH12020551043A1 (en) | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | |
| EP4497474A3 (en) | Methods of treating rheumatic diseases using trimetazidine-based compounds | |
| IL289919A (en) | Functionalized long-chain hydrocarbon mono- and di-carboxylic acids useful for the prevention or treatment of disease | |
| IL286549B (en) | Fixed dose combination of cannabinoids and medical mushrooms for prevention and treatment of cancer, inflammatory or immune‐mediated inflammatory diseases | |
| MX2017009417A (es) | Formas solidas de acido 2-(5-(3-fluorofenil)-3-hidroxipicolinamido )acetico, composiciones y usos de las mismas. | |
| JOP20200231A1 (ar) | ناهضات ppar (مستقبل ناشر بيروكسيزوم منشط)، ومركبات، ومكونات أدوية، وطرق استعمالها | |
| BR112018016359A2 (pt) | biopesticidas para doença de requeima da batata | |
| MX2022002056A (es) | Compuestos para el tratamiento de enfermedad respiratoria bovina o porcina. | |
| MX2024005705A (es) | Composiciones de liquidos ionicos. | |
| BR112017026061A2 (pt) | composto, uso de um composto, e, método de tratamento de uma infecção viral | |
| CY1122923T1 (el) | Παραγωγα 3-((ετερο-)αρυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου | |
| PH12021552974A1 (en) | Fused heterocyclic derivatives | |
| IL282375A (en) | 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating α-synucleinopathies, tauopathies, and other disorders | |
| EP3646770A4 (en) | SOFT ENDOSCOPE TUBE, ENDOSCOPE-TYPE MEDICAL DEVICE, RESIN COMPOSITION FOR COATING A SOFT ENDOSCOPE TUBE SUBSTRATE, AND RESIN COMPOSITION KIT FOR COATING A SOFT ENDOSCOPE TUBE SUBSTRATE | |
| DK3759083T3 (da) | 2,4-diaminoquinazolinderivater og anvendelse deraf til behandling af virusinfektioner, cancer eller allergier | |
| LT3586837T (lt) | Kompozicijos, apimančios aminorūgštis, skirtos panaudoti kepenų ligų prevencijai ir gydymui | |
| MX390418B (es) | Anticuerpos anti proteína similar a angiopoyetina 4 y métodos de uso. | |
| DK3452465T3 (da) | Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme | |
| DK3762000T3 (da) | Anvendelse af direkte tilførte mikrobielle midler til forebyggelse og/eller behandling af infektioner, der forårsages af e. coli, hos dyr | |
| DK3458440T3 (da) | Pyridinethioner, farmaceutiske sammensætninger deraf, og terapeutisk anvendelse til behandling af en proliferativ, inflammatorisk, neurodegenerativ eller immunmedieret sygdom | |
| WO2018060528A3 (en) | Therapeutic protein | |
| AR117741A1 (es) | Dominios de unión mixtos |